Article Text

Download PDFPDF
Symptomatic gastro-oesophageal reflux as a risk factor for oesophageal adenocarcinoma
  1. A J CAMERON,
  2. Y ROMERO
  1. Mayo Clinic, W19, 200 First Street SW
  2. Rochester, Minnesota 55905, USA
  1. Dr AJ Cameron. Email: cameron.alan{at}mayo.edu

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Comment

This study is a model of well planned and executed epidemiological research. Lagergren and colleagues conducted a case control study of risk factors for oesophageal adenocarcinoma. They obtained standardised information on personal history, endoscopy, and pathology in 85% of eligible cases of adenocarcinoma in the entire country of Sweden over three years. The strengths of the study design include using two control groups and taking steps to avoid reversed causality. The first control group comprised randomly selected age and sex matched subjects from the entire Swedish population. The second control group comprised patients with squamous oesophageal carcinoma who were not aware of their cancer type, which should exclude recall bias of symptoms compared with those with adenocarcinoma. By limiting recall of reflux symptoms to at least five years before the diagnosis of cancer, the chance that the tumour caused these symptoms was excluded.

Lagergren et al found that reflux had a strong association with oesophageal adenocarcinoma, a …

View Full Text

Footnotes

  • Potential conflict of interest: Dr A J Cameron is currently collaborating with Dr A J Lagergren.